MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Automated Diagnosis of Idiopathic Parkinson’s Disease Using Deep Convolutional Neural Networks

    YH. Sung, DH. Shin, EY. Kim (Incheon, Republic of Korea)

    Objective: The aim of this study is to implement and evaluate CNN-based DL approach for the     diagnosis of IPD. We trained CNNs on a…
  • 2019 International Congress

    Multi-modal MRI in patients with genetically confirmed familial cortical myoclonic tremor with epilepsy type 1

    F. Xie, B. Wang, J. Wang, Z. Cen, W. Wei, Y. Chen, H. Sun, D. Yang, Y. Lou, X. Chen, S. Chen, H. Wang, L. Wang, S. Wang, X. Qiu, Y. Ding, H. Yin, S. Wu, B. Zhang, Y. Zang, W. Luo (Hangzhou, China)

    Objective: The present study utilized multi-modal MRI study to investigate the structural and functional alterations in genetically confirmed familial cortical myoclonic tremor with epilepsy type…
  • 2019 International Congress

    Smartphone Applications Are Promising Modalities for Monitoring Parkinson’s Disease (PD) Symptoms

    M. Qazi, H. Ellsworth, J. Chou, F. Wang, N. Hellmers, C. Henchcliffe, H. Sarva (Ny, NY, USA)

    Objective: To review use of smartphone applications to monitor and manage PD. Background: Smartphone applications successfully monitor and manage chronic diseases. For patients with PD,…
  • 2019 International Congress

    Effect of deep brain stimulation on endothelial function and heart rate variability in Parkinson’s disease

    JH. Yoon, DG. Park (Suwon, Republic of Korea)

    Objective: We aimed to investigate whether deep brain stimulation (DBS) surgery could impact on the vascular endothelial function and heart rate variability in Parkinson’s disease…
  • 2019 International Congress

    Fixation suppression the easy way – when nothing else matters

    F. Gandor, M. Tesch, H. Neuhauser, D. Gruber, HJ. Heinze, G. Ebersbach, T. Lempert (Beelitz-Heilstaetten, Germany)

    Objective: to validate a simple bedside test to objectify the fixation suppression of the vestibulo-ocular reflex (FS-VOR) in patients with cerebellar syndrome Background: The FS-VOR…
  • 2019 International Congress

    Prevalence and associated risk factors of early morning off among the patients with Parkinson’s disease in China

    W. Mao, C. Han, J. An, Z. Liu, P. Chan (Beijing, China)

    Objective: To explore the prevalence and associated risk factors of early morning off (EMO) among outpatients with Parkinson’s disease (PD) in China. Background: PD is…
  • 2019 International Congress

    An explorative study on the value of clinical features for diagnosing Parkinson’s disease

    S. Suwijn, R. de Bie (Amsterdam, Netherlands)

    Objective: To investigate the usefulness of clinical features to differentiate subjects with “scans without evidence of dopaminergic deficit” (SWEDD) from patients presumed to have Parkinson’s…
  • 2019 International Congress

    Neuromelanin MRI detects monoaminergic cell loss in Huntington Disease Expansion Gene Carriers.

    ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)

    Objective: To measure, with NM-MRI, the integrity of neuromelanin-containing monoaminergic cells in the SN and LC in Huntington Disease Gene Expansion Carriers (HDGECs) and compare…
  • 2019 International Congress

    Grey-matter volume changes underpinning irritability and aggression in early manifest Huntington’s disease

    S. Martinez-Horta, F. Sampedro, J. Perez-Perez, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore grey-matter volume (GMV) differences between early-stage Huntington's disease (HD) patients with and without significant irritability/aggression symptoms (IAs) and to assess it association…
  • 2019 International Congress

    Quantitative Motor (Q-Motor) Assessments Suggest a Beneficial Central Effect of Laquinimod in a Phase II Study in Huntington Disease (LEGATO-HD)

    R. Reilmann, M. Gordon, R. Schubert, K. Anderson, A. Feigin, S. Tabrizi, B. Leavitt, J. Stout, P. Piccini, B. Borowsky, G. Rynkowski, R. Volkinshtein, J. Savola, M. Hayden (Muenster, Germany)

    Objective: Evaluate the change from baseline at week 52 in Q-Motor (Quantitative Motor) measures, exploratory, standardized, and rater-independent outcomes in the LEGATO-HD study. Background: LEGATO-HD…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley